Sod2tm1.1Kskk/Sod2+
involves: 129P2/OlaHsd * C57BL/6
|
abnormal myocardial fiber morphology |
J:98289
|
increased cardiomyocyte apoptosis |
J:98289
|
oxidative stress |
J:98289
|
Sod2tm1.1Kskk/Sod2tm1.1Kskk
involves: 129P2/OlaHsd * C57BL/6
|
abnormal myocardial fiber morphology |
J:98289
|
fatigue |
J:98289
|
oxidative stress |
J:98289
|
postnatal growth retardation |
J:98289
|
postnatal lethality, complete penetrance |
J:98289
|
Sod2tm1Cje/Sod2+
B6.Cg-Sod2tm1Cje/Mmmh
|
abnormal mitochondrial physiology |
J:108637
|
abnormal respiratory electron transport chain |
J:108637
|
increased lymphoma incidence |
J:87514
|
increased tumor incidence |
J:87514
|
normal
mortality/aging |
J:87514
|
oxidative stress |
J:87514,
J:108637
|
Sod2tm1Cje/Sod2+
D2.Cg-Sod2tm1Cje
|
abnormal mitochondrial physiology |
J:73998
|
Sod2tm1Cje/Sod2+
involves: C57BL/6J * CD-1
|
abnormal mitochondrial physiology |
J:67874
|
abnormal respiratory electron transport chain |
J:67874
|
increased hepatocyte apoptosis |
J:67874
|
oxidative stress |
J:67874
|
Sod2tm1Cje/Sod2+
involves: C57BL/6J * DBA/2J
|
abnormal tricarboxylic acid cycle |
J:73998
|
Sod2tm1Cje/Sod2tm1Cje
B6.Cg-Sod2tm1Cje/Mmmh
|
decreased fetal size |
J:73998
|
dilated cardiomyopathy |
J:73998
|
dilated heart left ventricle |
J:73998
|
dilated heart right ventricle |
J:73998
|
enlarged heart |
J:73998
|
lethality throughout fetal growth and development, incomplete penetrance |
J:73998
|
oxidative stress |
J:108637
|
perinatal lethality, complete penetrance |
J:73998
|
thin ventricular wall |
J:73998
|
Sod2tm1Cje/Sod2tm1Cje
D2.Cg-Sod2tm1Cje
|
abnormal blood gas level |
J:73998
|
abnormal blood homeostasis |
J:73998
|
abnormal enzyme/coenzyme level |
J:73998
|
abnormal mitochondrial physiology |
J:73998
|
abnormal urine homeostasis |
J:73998
|
cardiac hypertrophy |
J:73998
|
decreased body weight |
J:73998
|
decreased circulating glucose level |
J:73998
|
hepatic steatosis |
J:73998
|
hyperoxia |
J:73998
|
hypocapnia |
J:73998
|
increased blood urea nitrogen level |
J:73998
|
increased circulating alkaline phosphatase level |
J:73998
|
increased circulating aspartate transaminase level |
J:73998
|
increased circulating ketone body level |
J:73998
|
increased heart weight |
J:73998
|
metabolic acidosis |
J:73998
|
postnatal lethality, complete penetrance |
J:73998
|
Sod2tm1Cje/Sod2tm1Cje
involves: C57BL/6J
|
abnormal brainstem morphology |
J:45913
|
abnormal cerebellum morphology |
J:45913
|
abnormal cerebral cortex morphology |
J:45913
|
abnormal gait |
J:45913
|
abnormal optic nerve morphology |
J:71457
|
abnormal retina morphology |
J:71457
|
abnormal retina photoreceptor layer morphology |
J:71457
|
abnormal retina pigment epithelium morphology |
J:71457
|
ataxia |
J:45913
|
brain vacuoles |
J:45913
|
dilated cardiomyopathy |
J:45913
|
hepatic steatosis |
J:45913
|
impaired righting response |
J:45913
|
postnatal growth retardation |
J:45913
|
postnatal lethality, complete penetrance |
J:45913
|
spongiform encephalopathy |
J:45913
|
thin retina inner nuclear layer |
J:71457
|
tremors |
J:45913
|
Sod2tm1Cje/Sod2tm1Cje
involves: C57BL/6J * CD-1
|
abnormal aerobic respiration |
J:52592
|
abnormal cell physiology |
J:52592
|
abnormal liver physiology |
J:29899
|
abnormal skeletal muscle morphology |
J:29899
|
abnormal tricarboxylic acid cycle |
J:29899,
J:52592
|
calcinosis |
J:29899
|
cardiac fibrosis |
J:29899
|
cardiac hypertrophy |
J:29899
|
decreased body surface temperature |
J:29899
|
decreased circulating lactate level |
J:29899
|
decreased hematocrit |
J:29899
|
dilated cardiomyopathy |
J:29899
|
fatigue |
J:29899
|
hepatic steatosis |
J:29899
|
hypotonia |
J:29899
|
increased circulating ketone body level |
J:29899
|
increased liver weight |
J:29899
|
metabolic acidosis |
J:29899
|
organic aciduria |
J:52592
|
pallor |
J:29899
|
postnatal growth retardation |
J:29899
|
postnatal lethality, complete penetrance |
J:29899
|
Sod2tm1Cje/Sod2tm1Cje
involves: C57BL/6J * DBA/2J
|
abnormal blood homeostasis |
J:73998
|
abnormal blood pH regulation |
J:73998
|
abnormal brain morphology |
J:98007
|
abnormal brainstem morphology |
J:98007
|
abnormal enzyme/coenzyme level |
J:73998
|
abnormal forebrain morphology |
J:98007
|
abnormal frontal lobe morphology |
J:98007
|
abnormal gait |
J:98007
|
abnormal hippocampus morphology |
J:98007
|
abnormal skeletal muscle fiber morphology |
J:98007
|
abnormal thalamus morphology |
J:98007
|
abnormal tricarboxylic acid cycle |
J:73998,
J:98007
|
abnormal trigeminal motor nucleus morphology |
J:98007
|
abnormal trigeminal V mesencephalic nucleus morphology |
J:98007
|
abnormal urine homeostasis |
J:73998
|
acidosis |
J:73998
|
ataxia |
J:73998,
J:98007
|
axon degeneration |
J:98007
|
cardiac hypertrophy |
J:73998
|
decreased body weight |
J:73998
|
decreased circulating glucose level |
J:73998
|
decreased skeletal muscle fiber size |
J:98007
|
hyperoxia |
J:73998
|
hypocapnia |
J:73998
|
increased blood urea nitrogen level |
J:73998
|
increased circulating ketone body level |
J:73998
|
increased heart weight |
J:73998
|
normal
liver/biliary system phenotype |
J:73998
|
neuron degeneration |
J:98007
|
postnatal lethality, complete penetrance |
J:73998
|
seizures |
J:73998,
J:98007
|
tremors |
J:98007
|
Sod2tm1Kskk/Sod2tm1Kskk Tg(BEST1-rtTA,tetO-cre)1Yzl/0
B6.Cg-Sod2tm1Kskk Tg(BEST1-rtTA,tetO-cre)1Yzl
|
decreased a-wave amplitude |
J:282248
|
decreased b-wave amplitude |
J:282248
|
retina degeneration |
J:282248
|
retina pigment epithelium atrophy |
J:282248
|
thin retina outer nuclear layer |
J:282248
|
Sod2tm1Kskk/Sod2tm1Kskk Tg(BEST1-rtTA,tetO-cre)1Yzl/0
B6J.Cg-Sod2tm1Kskk Tg(BEST1-rtTA,tetO-cre)1Yzl
|
abnormal Bruch membrane morphology |
J:230153
|
abnormal cone electrophysiology |
J:230153
|
abnormal ocular fundus morphology |
J:230153
|
abnormal optic choroid morphology |
J:230153
|
abnormal retina photoreceptor layer morphology |
J:230153
|
abnormal retina pigment epithelium morphology |
J:230153
|
abnormal retina pigmentation |
J:230153
|
abnormal retina rod cell outer segment morphology |
J:230153
|
abnormal retina vasculature morphology |
J:230153
|
abnormal rod electrophysiology |
J:230153
|
oxidative stress |
J:230153
|
retina hemorrhage |
J:230153
|
retina photoreceptor degeneration |
J:230153
|
retina pigment epithelium atrophy |
J:230153
|
short photoreceptor inner segment |
J:230153
|
short photoreceptor outer segment |
J:230153
|
thin retina outer nuclear layer |
J:230153
|
Sod2tm1Leb/Sod2+
B6.129S7-Sod2tm1Leb/J
|
normal
hearing/vestibular/ear phenotype |
J:119972
|
Sod2tm1Leb/Sod2tm1Leb
B6.129S7-Sod2tm1Leb/J
|
abnormal hepatocyte morphology |
J:36148
|
abnormal lipid homeostasis |
J:36148
|
abnormal mitochondrial physiology |
J:36148
|
abnormal motor capabilities/coordination/movement |
J:36148
|
anemia |
J:36148
|
circling |
J:36148
|
decreased body length |
J:36148
|
decreased body size |
J:36148
|
decreased body weight |
J:36148
|
decreased bone marrow cell number |
J:36148
|
decreased skeletal muscle mass |
J:36148
|
decreased total body fat amount |
J:36148
|
dilated cardiomyopathy |
J:36148
|
fatigue |
J:36148
|
impaired myelopoiesis |
J:36148
|
neurodegeneration |
J:36148
|
pallor |
J:36148
|
postnatal growth retardation |
J:36148
|
postnatal lethality, complete penetrance |
J:36148
|
normal
reproductive system phenotype |
J:64299
|
thin ventricular wall |
J:36148
|
weakness |
J:36148
|
Sod2tm1Shs/Sod2+ Tg(Cdh16-cre)91Igr/0
involves: C57BL/6 * C57BL/6CrSlc
|
abnormal renal tubule epithelium morphology |
J:174099
|
oxidative stress |
J:174099
|
Sod2tm1Shs/Sod2tm1Shs
involves: C57BL/6 * DBA
|
normal
liver/biliary system phenotype |
J:78889
|
Sod2tm1Shs/Sod2tm1Shs Tg(CAG-cre)13Miya/0
involves: C57BL/6 * C57BL/6CrSlc
|
perinatal lethality, complete penetrance |
J:78889
|
Sod2tm1Shs/Sod2tm1Shs Tg(Cdh16-cre)91Igr/0
involves: C57BL/6 * C57BL/6CrSlc
|
abnormal renal tubule epithelium morphology |
J:174099
|
normal
cardiovascular system phenotype |
J:174099
|
decreased body weight |
J:174099
|
dilated distal convoluted tubule |
J:174099
|
normal
homeostasis/metabolism phenotype |
J:174099
|
normal
mortality/aging |
J:174099
|
oxidative stress |
J:174099
|
renal cast |
J:174099
|
normal
renal/urinary system phenotype |
J:174099
|
Sod2tm1Shs/Sod2tm1Shs Tg(Ckmm-cre)5Khn/0
involves: C57BL/6CrSlc * FVB
|
abnormal cardiac muscle tissue morphology |
J:117386
|
abnormal heart echocardiography feature |
J:117386
|
abnormal heart left ventricle morphology |
J:117386
|
abnormal mitochondrial ATP synthesis coupled electron transport |
J:117386
|
abnormal mitochondrial crista morphology |
J:117386
|
abnormal myocardium layer morphology |
J:117386
|
abnormal oxidative phosphorylation |
J:117386
|
abnormal skeletal muscle morphology |
J:117386
|
cardiac interstitial fibrosis |
J:117386
|
cardiac muscle necrosis |
J:117386
|
congestive heart failure |
J:117386
|
decreased body weight |
J:117386
|
decreased cardiac muscle contractility |
J:117386
|
decreased food intake |
J:117386
|
decreased locomotor activity |
J:117386
|
decreased mitochondrial size |
J:117386
|
dilated cardiomyopathy |
J:117386
|
dilated heart left ventricle |
J:117386
|
dilated heart ventricle |
J:117386
|
enlarged heart |
J:117386
|
fatigue |
J:117386
|
increased cardiac muscle glycogen level |
J:117386
|
increased heart weight |
J:117386
|
myocardial fiber degeneration |
J:117386
|
oxidative stress |
J:117386
|
postnatal growth retardation |
J:117386
|
premature death |
J:117386
|
Sod2tm1Shs/Sod2tm1Shs Tg(Ckmm-cre)5Khn/0
involves: FVB
|
abnormal enzyme/coenzyme activity |
J:171017
|
abnormal heart echocardiography feature |
J:171017
|
cardiac interstitial fibrosis |
J:171017
|
dilated cardiomyopathy |
J:171017
|
dilated heart |
J:171017
|
dilated heart left ventricle |
J:171017
|
increased heart weight |
J:171017
|
myocardial fiber degeneration |
J:171017
|
myocardial fiber disarray |
J:171017
|
oxidative stress |
J:171017
|
Sod2tm1Shs/Sod2tm1Shs Tg(TNNI2-icre)1Vrmn/0
involves: C57BL/6
|
abnormal enzyme/coenzyme activity |
J:155917
|
abnormal enzyme/coenzyme level |
J:155917
|
abnormal mitochondrial physiology |
J:155917
|
abnormal muscle contractility |
J:155917
|
abnormal muscle physiology |
J:155917
|
abnormal skeletal muscle fiber mitochondrial morphology |
J:155917
|
abnormal skeletal muscle morphology |
J:155917
|
abnormal tibialis anterior morphology |
J:155917
|
normal
adipose tissue phenotype |
J:155917
|
decreased aerobic running capacity |
J:155917
|
normal
growth/size/body region phenotype |
J:155917
|
normal
homeostasis/metabolism phenotype |
J:155917
|
impaired exercise endurance |
J:155917
|
increased muscle cell glucose uptake |
J:155917
|
increased muscle fatigability |
J:155917
|
normal
muscle phenotype |
J:155917
|
Sod2tm1Smel/Sod2tm1Smel Tg(KRT14-cre/ERT)20Efu/0
involves: C57BL/6J * CD-1
|
abnormal epidermis stratum corneum morphology |
J:226565
|
abnormal keratinocyte differentiation |
J:226565
|
abnormal mitochondrial ATP synthesis coupled electron transport |
J:226565
|
decreased epidermal stem cell number |
J:226565
|
decreased keratinocyte proliferation |
J:226565
|
delayed wound healing |
J:226565
|
early cellular replicative senescence |
J:226565
|
enhanced wound healing |
J:226565
|
skin lesions |
J:226565
|
thick epidermis |
J:226565
|
thin epidermis |
J:226565
|